 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- ||||||| AI201901 / Abdi Ibrahim Pharma
Trial completion, Trial completion date, Trial primary completion date: HILARIA: Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients (clinicaltrials.gov) - Sep 8, 2023
P3, N=210, Completed, Sponsor: Abdi Ibrahim Ilac San. ve Tic A.S.
Recruiting --> Completed | Trial completion date: Dec 2022 --> May 2023 | Trial primary completion date: Nov 2022 --> Mar 2023
- |||| AI201901 / Abdi Ibrahim Pharma
Trial completion date, Trial primary completion date: HILARIA: Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients (clinicaltrials.gov) - May 23, 2022
P3, N=264, Recruiting, Sponsor: Abdi Ibrahim Ilac San. ve Tic A.S.
Recruiting --> Completed | Trial completion date: Dec 2022 --> May 2023 | Trial primary completion date: Nov 2022 --> Mar 2023 Trial completion date: Feb 2022 --> Dec 2022 | Trial primary completion date: Dec 2021 --> Nov 2022
- |||||| AI201901 / Abdi Ibrahim Pharma
Enrollment open: HILARIA: Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients (clinicaltrials.gov) - May 12, 2021
P3, N=264, Recruiting, Sponsor: Abdi Ibrahim Ilac San. ve Tic A.S.
Trial completion date: Feb 2022 --> Dec 2022 | Trial primary completion date: Dec 2021 --> Nov 2022 Not yet recruiting --> Recruiting
- |||||||||| AI201901 / Abdi Ibrahim Pharma
New P3 trial: HILARIA: Efficacy and Safety Study of AI201901 in Allergic Rhinitis Patients (clinicaltrials.gov) - Jan 27, 2021
P3, N=264, Not yet recruiting, Sponsor: Abdi Ibrahim Ilac San. ve Tic A.S.